Julia Ying Zhu

Practice Areas

Chinese Mainland Capital Markets, Hong Kong & Overseas Capital Markets, Private Equity & Investment Funds

Professional Memberships

Vice President of the Second Council, Zhong Lun Charity Foundation

President of the Third Council, East China University of Political Science and Law Education Development Foundation

Publications

“Negotiable Instrument Law”, Henan University Press, 1993

“Practice Guide for Securities Lawyers”，China Financial Publishing House, 2001

“200 Questions for Securities Lawyers”, Shanghai Jiao Tong University Press, 2003

“New Energy Law Collection of Zhong Lun Law Firm”, Research Institute of Zhong Lun Law Firm, 2021

Personal

Ms. Julia Ying Zhu is an equity partner of Zhong Lun Law Firm. She has been practicing in the area of capital markets for decades, with a focus on M&A, securities and private equity investment, mainly in the sectors of healthcare, pharmaceuticals & life sciences, energy & power, environmental protection, real estate, urban infrastructure, logistics industry and Information and intelligent technology. Ms. Zhu is conscientious and rigorous and has a strong commitment to efficiency and execution. She is adept at handling large-scale and complex M&A deals. Moreover, she has developed an enviable reputation for effectively coordinating the firm’s resources and giving full play to teamwork to best serve clients’ business objectives. She is especially skilled in advising State-owned listed companies and large enterprise groups.

The transactions of Shanghai Pharmaceutical’s acquisition of Cardinal Health China and Sinotrans’s merger of Sinoair for listing through share swap advised on by Ms. Zhu were awarded Deals of the Year (2018) and Deals of the Year (2019) by China Business Law Journal. Her involvement in Shanghai Pharma Health’s acquisition of KDL Pharmacy and Baiji Pharmacy earned her the recognition by 2021 IFLR1000 China Awards.

Work Highlights

Securities Offering and Listing

Assisted with an allotment of shares by Shanghai Shenda Company Ltd.

Assisted with an allotment of shares by Shanghai Join Buy Co., Ltd.

Assisted with the listing of Henan Zhongfu Industry Co., Ltd. on the main board of SSE

Assisted with the listing of Goldenmars Technology Holdings Limited on the growth enterprise market of HKEX

Assisted SIIC Environment in its listing on the main board of the HKEX

Assisted Mabpharm in its listing on the main board of the HKEX

Assisted Tigermed in its listing on the main board of the HKEX

Assisted Biocytogen in its listing on the main board of the HKEX

M&A in Real Estate Area

Advised Shanghai Industrial Holdings Ltd. (0363.HK), subsidiary of SIIC, on its acquisition of Shanghai Urban Development (Group) Limited, a transaction worth CNY 3.7 billion. This case was listed as the largest foreign M&A case in Shanghai for the year of 2007 by ALB

Advised Shanghai Industrial Holdings Ltd. (0363.HK) on its acquisition of Neo-China Land (Holdings) Group Limited (0563.HK, renamed as Shanghai Industrial Urban Development Group Limited after the acquisition, “SIUD"), a transaction worth HKD 2.7 billion. This case was listed as one of the top 10 M&A cases for the year of 2010 by ALB

Advised SIUD on its acquisition of Shanghai Urban Development (Group) Co., Ltd., a transaction worth HKD 6.11 billion. This case was regarded as a typical case by HKEX for it constituted a very substantial acquisition and reverse takeover involving a new listing

Advised SIUD on its acquisition of Shanghai World Trade Center Co., Ltd., a transaction worth USD 579.3 million

Advised Taiping Insurance on its acquisition of a commercial real estate, a transaction worth CNY 1.8 billion

M&A in Pharmaceutical Area

Assisted Sinopharm Group in its acquisition of 60% of the equity in CSIMC through issuance of domestic shares

Advised Shanghai Pharmaceuticals on its acquisition of Cardinal China (this transaction was awarded Deals of the Year 2018 by China Business Law Journal）

Assisted Shanghai Pharmaceuticals in its acquisition of Techpool of Takeda China

Legal Services in Industrial Area

Assisted with the business reorganization and integration of AkzoNobel, a World Top 500 Company, after its acquisition of ICI Group

Acted as PRC counsel for the coating business system of Axalta

M&A in Infrastructure Area

Advised Shanghai Industrial Holdings Ltd. on its acquisition of Shanghai-Kunming highway (Shanghai section), a transaction worth about HKD 4.2 billion

Advised Shanghai Industrial Holdings Ltd. on its acquisition of ShenYu highway (Shanghai section, G50, previously named as Huqingping highway), a transaction worth CNY 1.222 billion

Advised SIIC Shanghai Investment (Group) Co., Ltd. on its acquisition of a 23.0584% equity stake in Hangzhou Bay Bridge Development Co., Ltd. from Sino-Steel, a transaction worth CNY 1.466 billion

M&A in Environment Protection and New Energy Areas

Advised a JV established by Shanghai Industrial Holdings Ltd. and HT-SAAE, an A-share listed company, on the JV’s acquisition of several photovoltaic power plants, with the transactions involving CNY 2.3 billion

Advised China Smarter Energy Group Holdings Limited (1004.HK) on its acquisition of several photovoltaic power plants in China

Advised SIIC Environment Holdings Ltd. on its acquisition of 50% shares in Shanghai Pucheng Thermal Power Co., Ltd., a transaction worth about CNY 530 million

Advised SIIC Environment Holdings Ltd. on its acquisition of a garbage power plant located in Dazhou, Sichuan, a transaction a worth about CNY 145 million

Advised SIIC and SIIC Environment on its acquisition of Longjiang Environmental Protection Group Co., LTD, which has more than a dozen sewage treatment and water project companies, a transaction worth RMB 620 million"

Expert in these Jurisdictions

PRC Bar

Experience

Partner, Zhong Lun Law Firm

Senior partner and management member and director of the Professional Committee of M&A, Shanghai AllBright Law Offices

Languages Spoken

Chinese

English